Holen Sie sich die Stockscreener-App
4.54
1.09%
-0.05
Schlusskurs vom Vortag:
$4.59
Offen:
$4.56
24-Stunden-Volumen:
444.85K
Relative Volume:
0.58
Marktkapitalisierung:
$310.63M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-96.66M
KGV:
-2.1116
EPS:
-2.15
Netto-Cashflow:
$-83.73M
1W Leistung:
-1.09%
1M Leistung:
+9.93%
6M Leistung:
-20.07%
1J Leistung:
-70.03%
1-Tages-Spanne:
$4.40
$4.70
1-Wochen-Bereich:
$4.37
$4.78
52-Wochen-Spanne:
$2.86
$16.62
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Firmenname
Olema Pharmaceuticals Inc
Sektor
Branche
Telefon
(415) 651-3316
Adresse
780 BRANNAN STREET, SAN FRANCISCO
Vergleichen Sie OLMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
4.54 | 314.05M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-02 | Eingeleitet | Goldman | Buy |
| 2024-01-30 | Eingeleitet | Citigroup | Buy |
| 2023-07-21 | Eingeleitet | Oppenheimer | Outperform |
| 2023-05-05 | Eingeleitet | CapitalOne | Overweight |
| 2023-02-22 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-06 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-06-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-12-07 | Fortgesetzt | Cowen | Outperform |
| 2020-12-14 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-12-14 | Eingeleitet | Cowen | Outperform |
| 2020-12-14 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten
What drives Olema Pharmaceuticals Inc. stock priceConsistently high yield - jammulinksnews.com
Olema Pharmaceuticals Inc. Stock Analysis and ForecastUnmatched profit growth - jammulinksnews.com
Is Olema Pharmaceuticals Inc. a good long term investmentTriple returns potential - jammulinksnews.com
What analysts say about Olema Pharmaceuticals Inc. stockRemarkable growth - jammulinksnews.com
What makes Olema Pharmaceuticals Inc. stock price move sharplyDaily Top Gainers - Newser
Why Olema Pharmaceuticals Inc. stock attracts strong analyst attentionFree Access to Group - Newser
How Olema Pharmaceuticals Inc. stock performs during market volatilityFree Top Growth Stock Recommendations - Newser
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Olema Oncology Awards $675K Worth of Stock Options to Key New Hires in Breast Cancer Research - Stock Titan
Deeper Dive: Understanding Olema Pharmaceuticals Inc (OLMA) Through its Various Ratios - DWinneX
Olema Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Two Sigma Investments LP Has $425,000 Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Squarepoint Ops LLC Grows Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
HC Wainwright Issues Pessimistic Outlook for OLMA Earnings - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Acquired by Wellington Management Group LLP - MarketBeat
Jane Street Group LLC Trims Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Q2 EPS Forecast for Olema Pharmaceuticals Lowered by Analyst - Defense World
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Two Sigma Advisers LP - Defense World
ProShare Advisors LLC Purchases 3,298 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Ru - GuruFocus
Olema Oncology Expands Team with 322,000 Share Options Grant to New Biotech Talent - Stock Titan
Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):